Pictured: Jedd Wolchok
In the Clinic
By Media Staff  |  Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Pictured: Marc Ladanyi & Gregory Riely
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, April 3, 2013

A new guideline has established standards for testing lung cancer tumors for genetic abnormalities, giving more patients a chance to benefit from targeted therapies.

Pictured: Paul Sabbatini
Q&A
By Media Staff  |  Tuesday, April 2, 2013

In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan-Kettering’s clinical research program.

Pictured: Kenneth Offit
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

Pictured: Yukio Sonoda
Video
By Memorial Sloan-Kettering  |  Wednesday, March 27, 2013

Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan-Kettering have the benefit of an entire team of physicians having input into their care.

Pictured: Cycle for Survival
Event
By Jim Stallard, MA, Writer/Editor  |  Monday, March 25, 2013

The indoor cycling fund-raiser, in its seventh year, has raised more than $31 million for rare cancer research at Memorial Sloan-Kettering.

Pictured: Ron Kraemer
Patient Story
By Memorial Sloan-Kettering  |  Friday, March 22, 2013

To treat his soft tissue sarcoma, 50-year-old Ron Kraemer chose Memorial Sloan-Kettering for care and support that could keep him playing music and working as a personal fitness trainer.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, March 20, 2013

Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

Pictured: Stephen Chung
Video
By Memorial Sloan-Kettering  |  Monday, March 18, 2013

Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.

Pictured: Peter Scardino
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, March 14, 2013

Dr. Scardino discusses strategies for how physicians and patients can make the best use of PSA testing and prostate cancer treatment.

Pictured: ESK1 Monoclonal Antibody
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, March 13, 2013

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Pictured: Dennis Chi & Richard Barakat
Q&A
By Allyson Collins, MS, Science Writer/Editor  |  Tuesday, March 12, 2013

Gynecology Service Chief Richard Barakat comments on a recent study indicating that women treated by more-experienced physicians receive the most-appropriate care for this aggressive form of cancer.

Pictured: John Mulhall
Q&A
By Media Staff  |  Friday, March 8, 2013

Dr. Mulhall, director of Memorial Sloan-Kettering’s Male Sexual and Reproductive Medicine Program, explains common concerns about male sexual health and offers advice for men and their partners.

Pictured: Raul Parra
Video
By Memorial Sloan-Kettering  |  Wednesday, March 6, 2013

Dr. Parra, who practices at Memorial Sloan-Kettering Basking Ridge, treats prostate, kidney, and bladder cancers with the goal of extending the lives of patients, and giving them the best possible quality of life.

Pictured: Massage Therapy
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Monday, March 4, 2013

Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, tingling, and pain — is a common chemotherapy side effect. Treatments are available to help improve your quality of life.

Center News

Subscribe to Our E-newsletter

Get the latest information about cancer care.